FROM MEDICAL RECORDS TO DIAGNOSTIC DIALOGUES
Revolutionizing Psychiatric Comorbidity Diagnosis with AI-Driven Dialogues
Our novel PsyCoTalk dataset and multi-agent framework provide a clinical-grounded approach to tackle the complex challenge of co-occurring psychiatric disorders, enabling more accurate diagnosis and treatment planning.
Addressing the Complexity of Psychiatric Comorbidity
Psychiatric comorbidity poses a significant challenge in clinical practice, yet existing AI models and datasets often fall short, focusing narrowly on single disorders. This limits the development of robust, DSM-5 grounded screening systems capable of handling the intricate co-occurrence and progression of multiple conditions.
3,000
Dialogues
4+
Core Disorders, 6 Combinations
5/10
Realism Score (Psychiatrist Validated)
9%
Increase in Diagnostic Accuracy
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Our Clinical-Grounded Approach
We introduce a novel two-stage pipeline to overcome limitations in multi-disorder psychiatric diagnosis. This framework integrates synthetic patient EMR construction with a multi-agent diagnostic dialogue generation system, meticulously aligned with clinical standards.
Enterprise Process Flow
Synthetic EMR Construction (PsyCoProfile)
→
Multi-Agent Diagnostic Dialogue Generation
→
Psychiatrist Validation
→
Multi-disorder Psychiatric Screening
PsyCoTalk: A New Benchmark for Comorbidity
PsyCoTalk is the first large-scale dialogue dataset supporting comorbidity, comprising 3,000 multi-turn diagnostic dialogues. It's grounded in 502 diverse synthetic EMRs, capturing real-world complexity across common comorbid conditions like Depression, Anxiety, Bipolar, and ADHD. Psychiatrists validated its realism and diagnostic validity.
| Feature | Real-World Dial | D⁴ | MDD-5k | PsyCoTalk |
|---|---|---|---|---|
| Multi-disorder Comorbidity Focus | No | No | No | Yes |
| Large-scale Dataset | ~1,000 | 1,339 | 5,000 | 3,000 |
| Avg. Dialogue Turns | N/A | 21.6 | 26.8 | 45.9 |
| Psychiatrist Validated Realism | High (6/10) | Medium (4/10) | Low (1/10) | High (5/10) |
| DSM-5 Grounded State Machine | N/A | No | Limited | Yes |
| Synthetic EMR Integration | No | No | No | Yes |
Driving Advanced AI for Mental Health
Our HDSM-guided multi-agent system significantly improves diagnostic accuracy, demonstrating robust performance across MDD, AD, ADHD, and BD. This dataset empowers the development of reliable screening systems that perform step-by-step, DSM-5 compliant reasoning for multi-disorder diagnoses.
+9%
Increase in Diagnostic Accuracy (HDSM-guided vs. Baseline)
PsyCoTalk provides a valuable resource for psychiatric comorbidity research, enabling the development and evaluation of models capable of multi-disorder psychiatric screening in a single conversational pass. This advancement is crucial for improving early-stage screening and creating more inclusive diagnostic tools, especially in settings with limited clinical resources.
Case Study: From EMR to Dialogue
Consider a 20-24 year-old female student presenting with anxiety and irritability, marked mood fluctuations, and fatigue. Her EMR reveals a history of major depressive disorder and generalized anxiety, with a family history of bipolar disorder. Our system generates a nuanced dialogue that systematically explores symptoms, personal history, and risk factors, leading to a diagnosis of 'Past major depressive episode and past generalized anxiety disorder'.
The dialogue meticulously follows SCID-5-RV protocols, asking questions about sleep disturbances, concentration, mood stability, and past events. For instance, the doctor asks: 'How long has this difficulty focusing lasted? Have you noticed any significant mood swings?' The patient responds: 'It's been about three months, and my mood's been pretty unstable. Sometimes I suddenly feel very down...'
This demonstrates the system's ability to mirror complex clinical interviews, providing a rich, context-aware interaction that goes beyond simple symptom checklists.
Calculate Your Potential ROI
See how much time and cost your enterprise could save by implementing AI-driven solutions for complex diagnostic tasks.
Estimated Annual Savings
Annual Hours Reclaimed
Your Path to Advanced AI Diagnostics
Our structured roadmap ensures a seamless integration of PsyCoTalk into your existing mental healthcare workflows, maximizing impact and efficiency.
Phase 1: Discovery & Customization
We begin by understanding your specific clinical needs and data infrastructure. This phase involves a deep dive into existing diagnostic protocols and identifying opportunities for integrating PsyCoTalk's multi-agent framework.
Phase 2: System Integration & Training
Our team assists with the technical integration of the PsyCoTalk framework, tailored to your environment. We provide comprehensive training for your clinical staff, ensuring proficiency in leveraging AI-driven diagnostic dialogues.
Phase 3: Pilot Deployment & Validation
A pilot program is initiated with real-world scenarios, closely monitoring performance and gathering feedback. This phase includes continuous validation by psychiatrists to confirm diagnostic accuracy and clinical utility in your specific context.
Phase 4: Scaling & Continuous Improvement
Upon successful pilot, we facilitate full-scale deployment across your organization. Ongoing support, performance monitoring, and iterative enhancements ensure long-term value and adaptation to evolving clinical standards.
Ready to Transform Psychiatric Diagnosis?
Explore how PsyCoTalk and our AI-driven diagnostic framework can enhance precision and efficiency in mental health screening for your organization.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat